Shanghai MicuRx Pharmaceutical Co Ltd
688373
Company Profile
Business description
Shanghai MicuRx Pharmaceutical Co Ltd is engaged in the discovery, development and commercialization of innovative medicines for unmet clinical needs.
Contact
No. 53 Edison Road
Building 101 and 2, Floor 1-4, Building 1
Pilot Free Trade Zone
Shanghai201210
CHNT: +86 2150900550
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
188
Stocks News & Analysis
stocks
Potentially catastrophic ruling for ASX company
We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks
4 charts on Nvidia’s record $4 trillion market cap
Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.
stocks
Could merger breathe new life into struggling ASX asset manager?
Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,815.30 | 5.00 | -0.06% |
| CAC 40 | 7,795.03 | 34.26 | -0.44% |
| DAX 40 | 24,094.11 | 161.20 | -0.66% |
| Dow JONES (US) | 44,306.73 | 64.78 | -0.15% |
| FTSE 100 | 8,978.36 | 37.24 | 0.42% |
| HKSE | 24,203.32 | 63.75 | 0.26% |
| NASDAQ | 20,587.39 | 1.87 | 0.01% |
| Nikkei 225 | 39,459.62 | 110.06 | -0.28% |
| NZX 50 Index | 12,678.69 | 7.99 | -0.06% |
| S&P 500 | 6,249.04 | 10.71 | -0.17% |
| S&P/ASX 200 | 8,570.40 | 9.70 | -0.11% |
| SSE Composite Index | 3,519.65 | 9.47 | 0.27% |